AstraZeneca PLC is 275.5x more valuable than Savara Inc by market capitalization ($286.27 B vs $1.04 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SVRA | AZN |
|---|---|---|
| Market cap | $1.04 B | $286.27 B |
| US-listed rank | #2602 | #45 |
| Revenue (latest FY) | $257.00K | - |
| Net income (latest FY) | -$118.84M | - |
| Net margin | -46240.1% | - |
| SEC filings | 1,331 | 1,004 |
AstraZeneca PLC is 275.5x more valuable than Savara Inc by market capitalization ($286.27 B vs $1.04 B).
Full pages: Savara Inc and AstraZeneca PLC, or browse the full rankings.